TRIM59 Drives Bladder Cancer Progression Through E3 Ligase‐Dependent K48‐Linked Degradation of PTRF
A previously unrecognized TRIM59–PTRF–AKT/c‐Myc axis that drives BLCA progression is defined and TRIM59 is highlighted as a potential prognostic biomarker and therapeutic target.